These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16260699)

  • 1. Building upon the standard of care in adjuvant therapy of high-risk melanoma.
    Kirkwood JM
    J Clin Oncol; 2005 Dec; 23(34):8559-63. PubMed ID: 16260699
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
    Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
    J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
    Schuchter LM
    J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant interferon therapy for melanoma.
    Hancock B; Wheatley K; Ives N; Gore M
    J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous head and neck melanoma: the old and the new.
    Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of primary and regional melanoma].
    Dreno B
    Rev Prat; 2004 Jun; 54(11):1203-9. PubMed ID: 15496027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemotherapy in patients with advanced head and neck mucosal melanoma.
    Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB
    Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapy of cutaneous melanoma.
    Mays SR; Nelson BR
    Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
    Moschos SJ; Kirkwood JM; Konstantinopoulos PA
    J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck.
    Ahn HJ; Na II; Park YH; Cho SY; Lee BC; Lee GH; Koh JS; Lee YS; Shim YS; Kim YK; Kang HJ; Ryoo BY; Yang SH
    Oral Oncol; 2010 Aug; 46(8):607-11. PubMed ID: 20615750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
    Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G
    Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant high-dose interferon therapy for high-risk melanoma.
    Ready N; Weinstock MA
    Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review.
    Ascierto PA; Gogas HJ; Grob JJ; Algarra SM; Mohr P; Hansson J; Hauschild A
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):149-61. PubMed ID: 22874771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Underutilization of anticancer agents--an example].
    Strannegård O; Thorén FB
    Lakartidningen; 2010 Dec 8-14; 107(49):3150; discussion 3150-1. PubMed ID: 21280349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interferon for adjuvant therapy in melanoma; although approved, not indicated].
    Groenewegen G; Osanto S; van der Rhee HJ; Punt CJ
    Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2160-2. PubMed ID: 11086492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon for melanoma.
    Richtig E; Langmann G
    Ophthalmology; 2010 Sep; 117(9):1861. PubMed ID: 20816255
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant interferon in melanoma - a resurrection?
    Middleton MR; Thatcher N
    Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.